Andersen-Gill model for the endpoint OS
| . | RFS . | ||
|---|---|---|---|
| Prognostic markers . | HR . | 95%-CI . | P . |
| Allogeneic HSCT | 0.50 | 0.21-1.17 | .11 |
| Autologous HSCT | 0.57 | 0.23-1.40 | .22 |
| Log10(WBC) | 1.34 | 0.64-2.80 | .44 |
| Log10(platelets) | 0.95 | 0.40-2.26 | .91 |
| % BM blasts (difference 10%) | 1.04 | 0.87-1.24 | .69 |
| Age (difference of 10 y) | 1.08 | 0.82-1.42 | .59 |
| Abnormal karyotype | 1.14 | 0.55-2.34 | .73 |
| . | RFS . | ||
|---|---|---|---|
| Prognostic markers . | HR . | 95%-CI . | P . |
| Allogeneic HSCT | 0.50 | 0.21-1.17 | .11 |
| Autologous HSCT | 0.57 | 0.23-1.40 | .22 |
| Log10(WBC) | 1.34 | 0.64-2.80 | .44 |
| Log10(platelets) | 0.95 | 0.40-2.26 | .91 |
| % BM blasts (difference 10%) | 1.04 | 0.87-1.24 | .69 |
| Age (difference of 10 y) | 1.08 | 0.82-1.42 | .59 |
| Abnormal karyotype | 1.14 | 0.55-2.34 | .73 |
WBC, white blood cell count.